POWERED BY

Portugal reduced antibiotic consumption by 5.2% between 2019 and 2025

PublishedNovember 22, 2026

Portugal reduced antibiotic consumption by 5.2% between 2019 and 2025, moving closer to the national target of a 9% reduction by 2030. Despite favourable trends in some indicators of bacterial resistance, others continue to highlight the need for integrated action on infection prevention and the appropriate use of antimicrobials.

In 2025, total antibiotic consumption stood at 18.3 defined daily doses (DDDs) per 1,000 inhabitants per day, compared with 19.3 in 2019. Antibiotics recommended as first-line treatment for many common infections accounted for 61.9% of consumption, below the European target of at least 65%.

Regarding bacterial resistance, a notable decrease of 31.3% was recorded in the estimated incidence of bloodstream infections caused by methicillin-resistant Staphylococcus aureus (MRSA) between 2019 and 2025, from 11.39 to 7.83 cases per 100,000 inhabitants. Conversely, bloodstream infections caused by Escherichia coli resistant to third-generation cephalosporins (+31.9%) and Klebsiella pneumoniae resistant to carbapenems (+107%, from 2.93 to 6.06 cases per 100,000 inhabitants) increased. These indicators refer only to bloodstream infections, not to all infections caused by these microorganisms.

The Directorate-General of Health (DGS), through its Programme for Infection Prevention and Control and Antimicrobial Resistance (PPCIRA), in coordination with INFARMED, I.P., and the National Institute of Health Dr Ricardo Jorge (INSA), is implementing initiatives that integrate infection prevention and control, appropriate diagnosis and the responsible use of antibiotics, strengthen surveillance and support the implementation of good practices in healthcare.

In this context, the national meeting “Preventing Infections, Preserving Antimicrobials – From Evidence to Implementation: Priorities until 2030” was held at the INFARMED auditorium on 18 November 2026, European Antibiotic Awareness Day. The event brought together healthcare professionals and sector organisations to analyse national results and discuss intervention priorities.

The meeting also included the signing of a protocol under the DRIVE-AMS project between the DGS (Directorate-General of Health), ULS São João (São João Local Health Unit), IPO Porto (Portuguese Oncology Institute of Porto) and ULS Tâmega e Sousa, aimed at strengthening antimicrobial stewardship programmes and promoting the appropriate use of antimicrobials. To mark European Antibiotic Awareness Day, the national digital awareness campaign on the prudent use of antibiotics, launched in 2025 and promoted by INFARMED (National Authority of Medicines and Health Products) in partnership with the DGS and INSA (National Institute of Health), will continue.

The DGS (Directorate-General of Health), INFARMED, I.P. (National Authority of Medicines and Health Products) and INSA (National Institute of Health) will continue to raise awareness among the public and healthcare professionals of the responsible use of antibiotics, helping to preserve the effectiveness of these medicines and protect public health. INFARMED, I.P. will also publish an edition of its Deep Dive publication dedicated to antibiotic consumption in Portugal and the European targets for 2030.

Source